0001140361-15-020736.txt : 20150518
0001140361-15-020736.hdr.sgml : 20150518
20150518174623
ACCESSION NUMBER: 0001140361-15-020736
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150515
FILED AS OF DATE: 20150518
DATE AS OF CHANGE: 20150518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THORATEC CORP
CENTRAL INDEX KEY: 0000350907
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 942340464
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1228
BUSINESS ADDRESS:
STREET 1: 6035 STONERIDGE DR
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: 9258478600
MAIL ADDRESS:
STREET 1: 6035 STONERIDGE DR
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: THORATEC CARDIOSYSTEMS INC
DATE OF NAME CHANGE: 20010220
FORMER COMPANY:
FORMER CONFORMED NAME: THORATEC LABORATORIES CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAVIOLETTE PAUL A
CENTRAL INDEX KEY: 0001191249
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49798
FILM NUMBER: 15874430
MAIL ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
4
1
doc1.xml
FORM 4
X0306
4
2015-05-15
0
0000350907
THORATEC CORP
THOR
0001191249
LAVIOLETTE PAUL A
6035 STONERIDGE DRIVE
PLEASANTON
CA
94588
1
0
0
0
Common Stock
2015-05-15
4
S
0
5668
44.6982
D
23477
D
Shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on September 12, 2013, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act 1934, as amended..
This transaction was executed in multiple trades in prices ranging from $44.43 to $44.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
/s/ David A. Lehman, Attorney-In-Fact
2015-05-18